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Evaluation of rapid alternative methods for drug susceptibility
testing in clinical isolates of Mycobacterium tuberculosis
Luciano Mengatto, Yosena Chiani, María Susana Imaz/+
Instituto Nacional de Enfermedades Respiratorias “E. Coni”, Blas Parera 8260, Santa Fe (3000) Argentina
A study was carried out to compare the performance of a commercial method (MGIT) and four inexpensive drug
susceptibility methods: nitrate reductase assay (NRA), microscopic observation drug susceptibility (MODS) assay,
MTT test, and broth microdilution method (BMM). A total of 64 clinical isolates of  Mycobacterium tuberculosis
were studied. The Lowenstein-Jensen proportion method (PM) was used as gold standard. MGIT, NRA, MODS, and
MTT results were available on an average of less than 10 days, whereas BMM results could be reported in about 20
days. Most of the evaluated tests showed excellent performance for isoniazid and rifampicin, with sensitivity and
specificity values > 90%. With most of the assays, sensitivity for ethambutol was low (62-87%) whereas for strepto-
mycin, sensitivity values ranged from 84 to 100%;  NRA-discrepancies were associated with cultures with a low
proportion of EMB-resistant organisms while most discrepancies with quantitative tests (MMT and BMM) were
seen with isolates whose minimal inhibitory concentrations fell close the cutoff. MGIT is reliable but still expensive.
NRA is the most inexpensive and easiest method to perform without changing the organization of the routine PM
laboratory performance. While MODS, MTT, and BMM, have the disadvantage from the point of view of biosafety,
they offer the possibility of detecting partial resistant strains. This study shows a very good level of agreement of the
four low-cost methods compared to the PM for rapid detection of isoniazid, rifampicin and streptomycin resistance
(Kappa values > 0.8); more standardization is needed for  ethambutol.
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The emergence of tuberculosis in conjunction with
the increasing number of multi-drug resistant strains of
Mycobacterium tuberculosis has increased the need for
rapid and reliable methods of diagnosis and drug suscep-
tibility testing (DST).
The Lowenstein-Jensen (LJ) or agar proportion
method (PM) (Canetti et al. 1963, 1969, Kent & Kubica
1985) and the radiometric method in BACTEC TB-460 sys-
tem (Becton-Dickinson) (Roberts et al. 1983) are the cur-
rent standard methods recommended to perform suscep-
tibility testing of M. tuberculosis. However they are ei-
ther time consuming or require the use of radioisotopes,
that should be disposed of. Recently, new commercial
methods were developed, including mycobacterial growth
Indicator Tube (MGIT) (Rusch-Gerdes et al. 1999) and
molecular tests such as INNOLIPA Rif TB (Innogetics,
Ghent, Belgium) (Rossau et al. 1997). However they are
rapid, but expensive, making them impractical for use in
developing countries.
A number of new simple and inexpensive methods for
drug susceptibility testing have been recently described.
The microscopic observation drug susceptibility (MODS)
assay is a liquid culture method based on microscopic
detection of characteristic M. tuberculosis morphology
(Caviedes et al. 2000). The broth microdilution method
(BMM) has shown to be a practical and rapid method to
determine minimum inhibitory concentrations (MICs)
of antituberculosis drugs (Leite el al. 2000, Coban et al.
2004). To improve the mycobacterial growing reading, an
association of this method with colorimetric compounds,
like the oxidation-reductor indicator MTT [3-(4.5-
dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide]
has been successfully used (Caviedes et al. 2002). An-
other new method recently developed is the nitrate reduc-
tase assay (NRA) based on the ability of M. tuberculosis
to reduce nitrate to nitrite; the reduction can be detected
by using specific reagents which produce color change
(Angeby et al. 2002).
In the present study 64 clinical isolates of M. tubercu-
losis were tested by a commercial method (MGIT) and
four inexpensive methods for DST: the MODS assay, the
BMM, the MTT reduction test, and the NRA. The ensu-
ing overall comparison provides a convenient frame of
reference for the reliability of these rapid DST methods in
the routine of the micobacteriology laboratories.
MATERIALS  AND  METHODS
Strains and inoculum preparation - A total of 64 clini-
cal isolates and H37Rv ATCC 27294 (sensitive to all the
antituberculosis agents) were evaluated in this study. The
M. tuberculosis strains were obtained from 64 different
patients whose isolates  were referred to the Laboratory
of the National Institute of Respiratory Diseases “E. Coni”
(Santa Fe, Argentine) for drug susceptibility testing be-
tween 2003 and 2005. All clinical isolates were grown in LJ
medium and tested in a blind manner for all different meth-
ods. The strains were defined as M. tuberculosis accord-
ing to growth rates, pigmentation, colony properties, and
routine biochemical methods (catalase, nitrate reduction,
and niacin accumulation tests) (Centro Panamericano de
Zoonosis 1988). Colonies from LJ were transferred to a
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tube containing 6-9 sterile glass beads and 3-4 ml of 7H9-
S broth  [Middlebrook 7H9 broth base (Difco, Sparks, MD,
US; 4.7 g/l), with 0.2% glycerol, supplemented with 10%
oleic-albumin-dextrose-catalase (OADC; Becton Di-
ckinson, Sparks, MD, US)]. Tubes were vigorously agi-
tated and clumps were allowed to settle 30 min. The su-
pernatants were then adjusted with distilled water to equal
the density of  a 0.5 McFarland standard to be used in  the
BMM, MGIT, and MODS assays and to equal the density
of a 1 McFarland standard to be used in the NRA, PM,
and MTT assays. The reference H37Rv was tested each
time the experiences were performed with clinical isolates.
Antituberculous drugs - Rifampicin (RIF), isoniazid
(INH), ethambutol (EMB), and streptomycin (SM) were
obtained in powder form from Sigma Chemical Co (St Louis,
MO, US). Stock solutions of INH, EMB, and SM were
prepared in deionized water at 10 g/l and RIF was pre-
pared in dimethylsulfoxide at 20 g/l. Stock solutions were
kept at –20ºC for no more than one month.
PM - The PM was performed on LJ medium according
to Canetti et al. (1963) with  the recommended critical con-
centrations of 0.2 µg/ml for INH, 40 µg/ml for RIF, 2 µg/
ml for  EMB, and 4 µg/ml for SM. To define drug-suscep-
tible from drug-resistant organisms, the PM was consid-
ered  the gold standard.
MODS assay - This assay was performed in  sterile 24-
well plates (Falcon, Becton Dickinson, Franklin Lakes, NJ,
US). To prepare the inoculum, the bacterial suspension,
adjusted to a turbidity equivalent to that of a 0.5 McFarland
standard,  was diluted  to 10-3 in 7H9-S broth. Antibiotic
working solutions were prepared at the following con-
centrations: INH, 1 and 4 µg/ml; RIF, 5 and 10 µg/ml; EMB,
25 and 37.5 µg/ml; SM, 20 and 60 µg/ml. Five hundred and
forty microliters aliquots of diluted bacterial samples were
distributed in wells of a 24-well plate. For each isolate, a
60 µl aliquot of each one of the drug working solutions
was added. Sixty microliters of 7H9-S broth was added in
a drug-free control well containing the diluted bacterial
suspension. Each plate contained an additional well of
drug-free medium; no bacteria were inoculated into this
well, which served as a control for cross contamination.
Plates were covered and sealed with plastic bags and in-
cubated at 37ºC in normal atmosphere. Starting on day 3,
every 1 or 2 days, wells were examined for the presence of
mycobacteria under an inverted light microscope (×40
magnification). For the purposes of this study, growth
was defined as the emergence of visually detectable ser-
pentine clusters of bacteria. If there was growth in the
control well then drug-containing wells were visualized
on the same day; growth in the presence of drug was
regarded as resistant whereas no growth in the presence
of drug was considered as susceptible. The final drug
concentrations were: INH, 0.1 and 0.4  µg/ml; RIF, 0.5 and
1  µg/ml; EMB, 2.5 and   3.75  µg/ml; SM, 2 and 6 µg/ml
(Caviedes et al. 2000, Moore et al. 2004).
MGIT - MGIT susceptibility testing was performed
according to the manufacturer’s recommendations. For
each isolate tested, three tubes were prepared: two con-
tained the antituberculosis drugs, and one was a drug-
free growth control. To all tubes, 0.5 ml of MGIT OADC
growth supplement (Becton Dickinson, Sparks, MD, US)
was added, and 0.1 ml of the antibiotic solution was also
added to each one of the drug-containing tubes, giving a
final concentration of 0.1 µg INH per ml and 1 µg RIF per
ml. All three tubes were then inoculated with 0.5 ml of a 1:5
dilution (in distilled water) of a standard inoculum, tightly
capped, and incubated at 37ºC. A positive MGIT control
tube was prepared by adding 5 ml of a 0.4% sodium sul-
phite solution to an empty MGIT tube. An uninoculated
MGIT tube, showing minimal or no fluorescence, served
as negative control. Starting on day 3, tubes were daily
examined for fluorescence by placing them on a 365 ηm
UV transiluminator. An isolate was considered as suscep-
tible whenever the tube containing the drug did not fluo-
resce within two days after the growth control tube fluo-
resced, and as resistant whenever the tube with the drug
was positive within 2 days of the positivity of the growth
control.
NRA - The NRA was performed as described  by
Angeby et al. (2002). Briefly, the antibiotic was included
in LJ medium at a concentration of: 0.2 µg/ml for INH, 40
µg/ml for RIF, 2 µg/ml for  EMB, and  4 µg/ml for SM; 1000
mg/l of potassium nitrate (KNO3) was also added. Part of
the inoculum, adjusted to equal the density of a 1
McFarland standard, was diluted 1:10 in distilled water.
For each isolate, 0.2 ml of  the undiluted inoculum was
added into the tubes containing  LJ medium with KNO3
and the antituberculosis drugs;  and 0.2 ml of the 1:10
dilution was inoculated into drug-free media containing
KNO3 (tubes in triplicate), serving the last three ones as
control growth. Tubes were incubated at 37ºC for 14 days
and 0.5 ml of a mixture of three reagents (1 part 50% con-
centrated hydrochloric acid, 2 parts 0.2% sulfanilamide
and 2 parts 0.1% N-1-naphthylenthylenediamine
dihydrochloride) was added to one drug-free control tube
after 7 days of incubation. If its colour changed to pink
then tubes with drugs were tested on the same day. An
isolate was considered resistant if there was a colour
change in the drug-tube greater than in the 1:10 diluted
growth control. If the drug-free control tube did not show
any colour change and remained the same, the remaining
tubes were further incubated, and the procedure repeated
on days 10 and 14 respectively.
MTT assay - The MTT assay was done as described
by Caviedes et al. (2002). Briefly, to prepare the inoculum,
the bacterial suspension adjusted to equal the density of
a 1 McFarland standard was diluted 1:25 with 7H9-S broth
and 100 µl was used as an inoculum.  Two hundred micro-
liters volume of sterile water was added to all outer wells
of sterile 96-well plates (Cellstar, Griener Bio-one,
Frickenhausen, Germany). One hundred microliters vol-
ume of 7H9-S broth was added in each well and serial two-
fold dilutions of each drug were prepared directly on the
plate by adding 100 µl of the drug working solutions (pre-
pared at four-fold the highest concentration tested on the
plates). The final drug concentration ranges were as fol-
lows: 0.125 to 32 µg/ml for INH, 0.062 to 16 µg/ml for RIF,
0.5 to 128 µg/ml for EMB and 0.125 to 32 µg/ml for SM.
One hundred microliters of the inoculum was added to
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the wells. Six growth controls containing no antibiotic
were included for each isolate. The plates were sealed,
placed in plastic bags and incubated at 37ºC at normal
atmosphere. On day-5, 50 µl of the tetrazolium-Tween 80
mixture {1.5 ml of tetrazolium[3-(4,5-dimethylthiazol-2-yl)-
2,5diphenyl-tetrazolium bromide] [ICN Biomedicals, Au-
rora, Oh, US] at a dilution of 1 mg/ml in absolute ethanol
and 1.5ml of 10% Tween 80} was added to one growth
control and the plate was then incubated at 37ºC for 24 h.
If this well turned purple, the tetrazolium-Tween 80 mix-
ture was added to all wells and the colour was recorded at
24 h. Otherwise, if the growth control well remained yel-
low the plate was then incubated at 37ºC for 24 h, after
which tetrazolium-Tween 80 mixture was added to another
control before the plate was incubated for another 24 h. If
this well remained yellow, incubation was continued and
tetrazolium-Tween 80 solution was added to each of the
remaining four controls on days 9, 11, 13, and 15. The
minimal inhibitory concentration (MIC) was defined as
the lowest concentration of each drug that prevented the
colour change and the strains were considered suscep-
tible to each drug, if their MICs were below or equal to the
critical concentration reported by Montoro et al. (2005);
INH, 0.25 µg/ml; RIF, 0.25 µg/ml; EMB, 4 µg/ml; SM, 1
µg/ml.
BMM assay - This assay was performed in sterile 96-
well plates (Cellstar) as described by Leite el al. (2000)
with minor modifications. Briefly, to prepare the inocu-
lum, the bacterial suspension adjusted to equal the den-
sity of a 0.5 McFarland standard was diluted 1:25 with
7H9-S broth and 100 µl was used as an inoculum. One
hundred microliters volume of 7H9-S broth was added in
each well and serial two-fold dilutions of each drug were
prepared directly on the plate by adding 100 µl of the drug
working solutions (prepared at four-fold the highest con-
centration tested on the plates). The final drug concen-
trations obtained were the same as described before for
MTT. One hundred microliters of the inoculum was added
to the wells. A well without antimycobacterial agent was
also inoculated with 10-2 dilution of the inoculum as
growth control. The plates were sealed, placed in plastic
bags and incubated at 37ºC for 28 days in normal atmo-
sphere. MIC was defined as the lowest drug concentra-
tion that exhibited no growth by visual reading, and the
strains were considered susceptible to each drug, if their
MICs were below or equal to the critical concentration
reported by Wallace et al. (1986); INH, 1 µg/ml; RIF, 1 µg/
ml; EMB,  8 µg/ml; SM, 2 µg/ml.
Costs - All costs were calculated using recent pur-
chase records. Costs for labor were not included.
Data analysis - The performances of the MGIT,
MODS, BMM, MTT, and NRA methods in comparison
with the PM were evaluated in terms of sensitivity  (abil-
ity to detect true resistance) and specificity (ability to
detect true susceptibility). The agreement between the
above mentioned assays and the PM was estimated by
the Kappa statistic. The kappa value, a measure of a test
reliability, was interpreted as follows: < 0.2, poor; 0.21 to
0.4, fair; 0.41 to 0.6, moderate; 0.61 to 0.8, good; > 0.81,
excellent (Altman 1999).
RESULTS
Patterns of susceptibility to INH, RIF, EMB, and SM
for 64 M. tuberculosis isolates were determined by PM.
Out of 64 cultures, 26 (40%) were resistant to INH, 25
(39%) to RIF, 19 (30%) to SM, and 8 (13%) to EMB. Twenty
nine cultures were fully drug-susceptible, 7 were
monoresistant, 16 were resistant to two drugs and 9 to
three drugs.
Susceptibility testing results
Isoniazid - The PM results with INH were compared
with those obtained by  the MGIT, NRA, MODS0.4µg/ml,
MODS0.1µg/ml, MTT, and BMM methods (Table I).
As regards susceptible cultures, only MGIT and
MODS0.1µg/ml assays, which use a lower INH critical con-
centration (0.1 µg/ml) than that employs by the reference
PM (0.2 µg/ml),  misidentified as resistant one of the 38
susceptible cultures (the same isolate in both methods).
Out of 26 INH resistant cultures, three (12%) were sus-
ceptible with  MODS0.4µg/ml assay; of these three isolates,
the MICs by MTT for two isolates were 0.5 µg/ml (one
dilution  (twofold) higher than the MTT-cutoff value) and
the MIC for one isolate was 0.25 µg/ml (at the MTT-cutoff
value). Thus, when 0.1 µg/ml was used as critical concen-
tration in MODS method, the agreement was 100%. The
NRA, MTT, and BMM assays failed to detect 2, 1, and 3
resistant strains, respectively, whereas MGIT gave 100%
agreement; these discordant results were found in only 3
isolates (the same as in the MODS0.4µg/ml); although the
BMM showed the poorest sensitivity, the MICs of the
three discordant strains were only at or one (twofold) di-
lution lower than the cutoff value.
Sensitivity values for MGIT, NR, MODS0.4µg/ml,
MODS0.1µg/ml, MTT, and BM methods were 100, 92, 88,
100, 96, and  88%, respectively, and specificity values
were 97, 100, 100, 97, 100, and 100%, respectively.
Rifampicin -  Complete agreement was found between
the results found with the MGIT, NRA, MODS1µg/ml,
MODS0.5µg/ml, MTT, and BMM methods compared with
those obtained with the PM (Table II).
Ethambutol - The PM results with EMB were com-
pared with those obtained by the NRA, MODS3.75µg/ml,
MODS2.5µg/ml, MTT, and BMM methods (Table III).
Specificity  values were high in all methods (98, 98, 98,
96, and 100% by NR, MODS3.75µg/ml, MODS2.5µg/ml, MTT,
and BM methods, respectively). However, low sensitivi-
ties were obtained with most of the tests, with values of
75, 62, 75, 87, and  62% by the NRA, MODS3.75µg/ml,
MODS2.5µg/ml, MTT, and BMM methods, respectively. The
two discordant results designated resistant by the PM
and susceptible by the NRA  were found in cultures with
only  a very small proportion of their bacterial population
(between 1 to 10%) that was detected to be EMB-resis-
tant  by the PM (cultures designated as borderline; Siddiqi
et al. 1985). The MICs of most of the discordant results (2
of the 3 isolates) designated resistant by the PM and sus-
ceptible by BMM were found to be at the cutoff value.
The same cultures were associated with the discordant
results obtained with MTT and MODS assays.
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TABLE I
Isoniazid susceptibility  test results by different techniques
Determination
(Drug critical concentration µg/ml)
MGIT NRA MODS MODS MTT BMM
(0.1) (0.2) (0.4) (0.1) (0.25) a (1) a
Proportion No. of No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
method isolates R    S R S    R S R S R S R S
Resistant 26  26 (100) 0 (0) 24 (92) 2 (8) 23 (88) 3 (12)  26 (100) 0 (0) 25 (96) 1 (4) 23 (88) 3 (12)
Susceptible 38 1 (3) 37 (97) 0 (0)   38 (100)  0 (0) 38(100) 1 (3) 37 (97) 0 (0)  38 (100) 0 (0) 38 (100)
Kappa value 0.97 b 0.93 b 0.90 b 0.97 b 0.97 b 0.90 b
MGIT: mycobacterial growth indicator tube; NRA: nitrate reductase assay; MODS: microscopic observation drug susceptibility;
MTT: MTT reduction test; BMM: broth microdilution method; a: in quantitative tests, the cutoff value could be considered the
critical concentration used for other drug susceptibility tests to separate susceptible from resistant isolates.
The Kappa value is a measure of test reliability with values interpreted as follows: ≤ 0.2, poor; 0.21 to 0.4, fair; 0.41 to 0.6, moderate;
0.61 to 0.8, good; ≥ 0.81, excellent; b: p < 0.001.
TABLE II
Rifampicin susceptibility  test results by different techniques
Determination
(Drug critical concentration µg/ml)
MGIT NRA MODS MODS MTT BMM
(1) (40) (1) (0.5) (0.25) a (1) a
Proportion No. of No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
method isolates R    S R S    R S R S R S R S
Resistant 25   25 (100)  0 (0)   25(100) 0 (0)  25 (100) 0 (0)  25 (100) 0 (0) 2 5 (100) 0 (0)  25 (100) 0 (0)
Susceptible 39 0 (0)  39 (100) 0 (0)   39 (100) 0 (0)  39 (100) 0 (0)  39 (100) 0 (0) 39(100) 0 (0)  39 (100)
Kappa value 1.00 b  1.00 b  1.00 b  1.00 b 1.00 b  1.00 b
MGIT: mycobacterial growth indicator tube; NRA: nitrate reductase assay; MODS: microscopic observation drug susceptibility;
MTT: MTT reduction test; BMM: broth microdilution method; a: in quantitative tests, the cutoff value could be considered the
critical concentration used for other drug susceptibility tests to separate susceptible from resistant isolates.
The Kappa value is a measure of test reliability with values interpreted as follows: ≤ 0.2, poor; 0.21 to 0.4, fair; 0.41 to 0.6, moderate;
0.61 to 0.8, good; ≥ 0.81, excellent; b: p < 0.001.
TABLE III
Ethambutol susceptibility  test results by different techniques
Determination
(Drug critical concentration µg/ml)
NRA MODS MODS MTT BMM
(2) (3.75) (2.5) (4) a (8) a
Proportion No. of No. (%) No. (%) No. (%) No. (%) No. (%)
method isolates R S    R S R S R S R S
Resistant  8  6 (75)  2 (25)  5 (62)  3 (38)  6 (75)  2 (25)   7 (87) 1 (13) 5 (62) 3 (38)
Susceptible 56 1 (2) 55 (98) 1 (2) 55 (98) 1 (2) 55 (98) 2 (4) 54 (96) 0 (0) 56 (100)
Kappa value 0.77 b 0.68 b 0.77 b 0.80 b 0.74 b
MGIT: mycobacterial growth indicator tube; NRA: nitrate reductase assay; MODS: microscopic observation drug susceptibility;
MTT: MTT reduction test; BMM: broth microdilution method; a: in quantitative tests, the cutoff value could be considered the
critical concentration used for other drug susceptibility tests to separate susceptible from resistant isolates.
The Kappa value is a measure of test reliability with values interpreted as follows: ≤ 0.2, poor; 0.21 to 0.4, fair; 0.41 to 0.6, moderate;
0.61 to 0.8, good; ≥ 0.81, excellent; b: p < 0.001.
Streptomycin - The PM results with SM were com-
pared with those obtained by the NRA, MODS6µg/ml,
MODS2µg/ml, MTT, and BMM methods (Table IV).
As regards susceptible isolates, only MTT and BMM
methods misidentified as resistant three and two cultures,
respectively. None of the isolates classified as suscep-
tible by the PM were highly resistant by MTT and BMM
methods; their corresponding MICs by MTT and BMM
methods were only one (twofold) dilution higher than the
cutoff value of each method.
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Out of the 19 SM-resistant cultures, six (32%) were
misidentified as susceptible by MODS6µg/ml.  Of these six
isolates with discordant results, the MICs by MTT for
one isolate was 0.5 µg/ml (one dilution lower than the
MTT-cutoff value),  for two isolates were 2 µg/ml (one
dilution off the MTT-cutoff value), for two isolates were 4
mg/ml and for the remaining isolate was 8 µg/ml. Further-
more, when 2 µg/ml was used in MODS method, the per-
centage of discordant results decreased to 10% (2 from
19). For NRA, 3 of the 19 resistant isolates were found
susceptible, giving a low level of sensitivity (84%).
Overall, sensitivity values for the NRA, MODS6µg/ml,
MODS2µg/ml, MTT, and BMM methods were 84, 68, 89, 95,
and 100%, respectively, whereas the specificity values
were 100, 100, 100, 93, and 96%, respectively.
Costs - Table V shows the estimated costs per strain
for susceptibility testing. Costs were calculated for two
first-line anti-TB drugs  (INH and RIF), and for four first-
line drugs (INH, RIF, EMB, SM). Items included in cost
analysis are noted below the Table.
Turnaround time (TAT) - The average time required to
obtain a susceptibility result by  the MGIT, NRA, MODS,
and  MTT methods was 6.4 days (range, 3 to 13), 9 days
(range, 7 to 14), 7 days (range, 4 to 14) and 7.7 days (range,
7 to 17), respectively. As regards BMM, MICs could be
read when organisms had reached good macroscopic
growth in control wells, generally after 14-17 days, but
the reading was repeated every two days up to day 28 of
incubation. More than half of the strains had no change
in the MIC value from day 14 to 20 of incubation; almost
75% of changes involving only one dilution. None of the
strains had change in MICs after day 20 of incubation.
Furthermore, considering some authors´ concerns on the
fact that early readings might result in false susceptibility
if a heterogeneous population of resistance was present,
we chose to use the 20-day reading time (Wallace et al.
1986).
DISCUSSION
Recently, new methods for rapid determination of M.
tuberculosis DST have been described, viz MGIT, NRA,
MODS, MTT, and BMM assays. In practice, these meth-
ods vary greatly, especially in the type of medium used
and in the drug concentration in the medium. Each method
has been successfully tested in previous studies (Rusch-
Gerdes et al. 1999, Leite el al. 2000, Caviedes et al. 2000,
2002,  Angeby et al. 2002, Park et al. 2002), showing that
TABLE IV
Streptomycin susceptibility  test results by different techniques
Determination
(Drug critical concentration µg/ml)
NRA MODS MODS MTT BMM
(4) (6) (2) (1) a (2) a
Proportion No. of No. (%) No. (%) No. (%) No. (%) No. (%)
method isolates R S    R S R S R S R S
Resistant 19 16 (84) 3 (16) 13 (68) 6 (32) 17 (89) 2 (11) 18 (95) 1 (5)  19 (100) 0 (0)
Susceptible 45 0 (0) 45 (100) 0 (0) 45 (100) 0 (0) 45 (100) 3 (7) 42 (93) 2 (4) 43 (96)
Kappa value 0.88 b 0.75 b 0.92 b 0.85 b   0.93 b
MGIT: mycobacterial growth indicator tube; NRA: nitrate reductase assay; MODS: microscopic observation drug susceptibility;
MTT: MTT reduction test; BMM: broth microdilution method; a: in quantitative tests, the cutoff value could be considered the
critical concentration used for other drug susceptibility tests to separate susceptible from resistant isolates.
The Kappa value is a measure of test reliability with values interpreted as follows: ≤ 0.2, poor; 0.21 to 0.4, fair; 0.41 to 0.6, moderate;
0.61 to 0.8, good; ≥ 0.81, excellent; b: p < 0.001.
TABLE V
Cost per strain for susceptibility testing
                                Susceptibility cost (U$) a
Method Two drugs Four drugs
Mycobacterial growth indicator tube (MGIT) b 19.52 NA
Nitrate reductase assay c 0.17 0.24
Microscopic observation drug susceptibility assay d 1.57 2.17
[3-(4.5-dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide] (MTT) assay e 2.23 3.96
Broth microdilution method f 2.07 3.63
a: two drugs, INH and RIF; four drugs, INH, RIF, EMB, and SM; b: includes costs of MGIT (prepared tubes), OADC, and
antimicrobial drugs; c: includes costs of LJ medium, glycerol, eggs, potassium nitrate, and antimicrobial drugs; d: calculated for two
different concentration of each drug. Includes costs of Middlebrook 7H9 medium, glycerol, OADC, 24-well plate (three and two
strains per plate for two and four drugs susceptibility testings, respectively), and antimicrobial drugs; e: includes costs of Middlebrook
7H9 medium, glycerol, OADC, MTT reagent, 96-well plate (one and two strains per plate for four and two drug susceptibility
testings, respectively), and antimicrobial drugs; f: includes costs of Middlebrook 7H9 medium, glycerol, OADC, 96-well plate (one
and two strains per plate for four and two drug susceptibility testings, respectively), and antimicrobial drugs; NA: not applicable.
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results can be obtained faster than with the PM, but, to
the best of our knowledge, they have never been com-
pared together.
Our data demonstrated that the evaluated methods
have an excellent test performance for INH and RIF (sen-
sitivity and specificity values higher than 90% with most
of the tests). Results with the other first line anti-tubercu-
losis drugs, SM and EMB, but especially with EMB,
showed some discrepancies. Some of the important fac-
tors, which may have contributed to these discrepancies,
are: (i) a low proportion of drug resistant organisms in the
test population of a culture, (ii) substantial differences in
the medium used by the methods, and (iii) different peri-
ods of incubation, which may be associated with differ-
ent degrees of degradation of the antimicrobial agent.
In quantitative tests like MTT and BMM methods,
the cutoff value is considered the drug concentration that
would separate susceptible from resistant isolates. In these
tests, this value could be interpreted as the critical con-
centration used for other DST methods to distinguish
susceptible from resistant strains (Heifets 2000). Never-
theless, care should be taken when interpreting MIC val-
ues close the critical concentration, since like in some
other studies evaluating quantitative DST methods
(Franzblau et al. 1998, Luna Herrera et al. 2003), in our
work, most discrepancies among the PM and MTT or BMM
were seen with isolates whose MICs fell at or one dilution
(twofold) higher or lower than the cutoff value.  Based on
these observations, some authors (Heifets et al. 1990,
Franzblau et al. 1998, Luna-Herrera et al. 2003) have sug-
gested  the use of a partially resistant range that is close
to the cutoff value, proposing the existence of three cat-
egories of susceptibility: susceptible, partially resistant
(isolates with borderline MICs) and resistant. The use of
these categories would allow the identification of TB due
to low-level resistant strains, making possible the use of a
drug up to near the maximum concentration that it could
reach in the human body. In this respect, some evidences
indicate that the use of high-dose isoniazid in TB
retreatment regimens, in spite of the acquired isoniazid
resistance, could improve therapeutic results, if all or part
of the organisms were resistant to only a low concentra-
tion of that drug (Moulding 1981).
Similarly, the use of double drug critical concentration
with MODS test allowed the identification of 11% (3 of
26) INH-resistant strains and 21% (4 of 19) SM-resistant
strains, that grew in low but not in high concentration of
drugs; their corresponding MICs determined by MTT fell
into the INH and SM partially resistant ranges proposed
by Franzblaw et al. (1998) (between 0.25 and 0.5 µg/ml for
INH and between 2 and 8 µg/ml for SM). Therefore, and
taking into account these authors’ notion of three cat-
egories of susceptibility, these strains could be consid-
ered low-level resistant strains.
Twenty five percent (2 out of 8) EMB-resistant strains
were misidentified as susceptible by NRA. Interestingly,
among the eight true EMB-resistant strains, these two
cultures were the only ones with a very small – from 1 to
10% – proportion  of the bacterial population  showing to
be resistant by the PM (cultures designated as border-
line; Siddiqi et al. 1985). The NRA was standardized to
consider a strain “resistant” when the drug-containing
tube inoculated with an undiluted suspension of bacilli
exhibited a nitrate reductase (NR) activity greater than
that appearing in the 1:10 diluted growth control (where
about 10% of the original inoculum was added). In “bor-
derline” strains, it would be expected that only about less
than 10% of the organisms could grow in the EMB-con-
taining tube, so that it is probable that the NR activity
exhibited by the drug-containing tube was lower than that
obtained in the 1:10 diluted growth control tube. Further-
more, some authors have shown that these “borderline”
cultures, more frequently associated with EMB resistance,
have classically caused problems in the interpretation of
EMB DST (Siddiqi et al. 1985), adversely affecting the
assays overall performance. On the other hand, for SM,  a
low level of sensitivity was obtained. Similar results were
reported by Martin et al. (2005) in their multicenter evalu-
ation of the NRA. A possible interaction between the drugs
and the potassium nitrate was speculated as a cause of
this discrepancy.
The turnaround time (TAT) is important in order for
the patient to receive an appropriate treatment. The re-
sults obtained with MGIT, MODS, NRA, and MTT were
available on an average of less than 10 days as with the
reference method BACTEC-460. The BMM, although con-
suming more time than the other four evaluated tests,
could be still reported faster (about 20 days) than the PM
(28-40 days).
Caviedes et al. (2000), in their evaluation of MODS
assay for DST, defined a “resistant strain” whenever the
growth in the presence of drug is microscopically observed
on the same day when the growth in control wells is de-
tected; suggesting that the wells have to be microscopi-
cally examined every one or two days.  This high fre-
quency of checking obviously yielded the fastest results,
and at first, one could anticipate that it would prevent
that true susceptible strains could be misidentified as re-
sistant, if  the time between the appearance of “any growth
in the drug-containing wells” of susceptible cultures and
“that in the control wells” were too short. In our study, we
tested that this period was about 10 days minimum (dur-
ing the 28-day incubation period, about 90% of suscep-
tible strains showed no growth in the drug-containing
wells), allowing, if necessary, to perform the microscopic
observation at intervals suitable to the laboratory
workload, thus adding an operational advantage to this
method.
RIF resistance is considered to be a strong predictor
of the presence of multidrug-resistant tuberculosis, espe-
cially in countries with high prevalence of drug resistance
(Rossau et al. 1997). Therefore, the complete agreement in
RIF-susceptibility results found for all the methods stud-
ied in this work indicates the potential of any of this simple
and inexpensive assays for control programs in countries
with high levels of tuberculosis endemicity.
In accordance with previous studies, this work showed
that MGIT system is a reliable, rapid and convenient
method for performing INH and RIF susceptibility tests,
but too expensive to implement in low-resources coun-
tries. Indeed, cost was the factor that prohibited us its
evaluation with EMB and SM. This study showed that
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using low-costs “in house” assays for rapid detection of
susceptibility, good or excellent  levels of agreement with
the PM were obtained. The NRA seems to be the most
inexpensive method; the medium used is the classical LJ
with the same concentration of antimicrobial drugs that is
used for the PM; it is easy to perform without changing
the organization of the routine laboratory performing DST.
However NRA gives only qualitative results. On the other
hand, both microdilution susceptibility tests (MTT and
BMM) and MODS assay offer the advantage of identify-
ing partial resistance but have the disadvantage from the
point of view of biosafety because manipulation of plates
could generate aerosols. Placement of the plate in a trans-
parent plastic bag, appropriately secured, adds an ele-
ment of biosafety. In this regard, results obtained by
MODS and BMM, which are methods based on the direct
microscopic or macroscopic growth observation, do not
require the addition of any reagent (like in MTT), thus the
sealed plates should not be opened and, consequently,
the biohazard potential might be reduced in the case that
the plate is mishandled.
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